Singapore, April 7 -- Japan-based Marubeni Corporation has concluded a Share Purchase Agreement with Sumitomo Pharma Co. to acquire shares in a newly established company that will take over Sumitomo Pharma's pharmaceutical sales business in Asia through a simplified absorption. Marubeni will acquire 60% of the issued shares of the new company for approximately 45 billion yen (Euro).

Published by HT Digital Content Services with permission from BioSpectrum Asia....